NOVAVAX – DATA SHOWED COVID-19 VACCINE CANDIDATE DRAMATICALLY REDUCED MILD AND MODERATE DISEASE ACROSS UK, SOUTH AFRICA TRIALS

PUBLISHED: Thu, 11 Mar 2021 21:02:03 GMT
Share

NOVAVAX – DATA SHOWED COVID-19 VACCINE CANDIDATE DRAMATICALLY REDUCED MILD AND MODERATE DISEASE ACROSS UK, SOUTH AFRICA TRIALS

Sign Up for Our Newsletter Daily Update

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.

(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html